The objective of the Fluorescence Microscopy Shared Resource is to provide the equipment, software and expertise necessary for the imaging of live and fixed cells. The impact of this facility on its users is largely dependent on how easily the equipment and software can be applied to the experimental questions posed by the researcher. This objective is fulfilled by providing consistent management of current equipment and ensuring that sufficient personnel are available to develop specific protocols and adapt equipment to address the specific scientific questions of resource users. Equipment/Software: The facility has two Olympus Fluoview confocal microscopes, a Yokagowa spinning disk confocal for low-light live cell imaging, and two widefield microscopes equipped with digital cameras. In addition, equipment for preparing live samples is available, including a cell culture incubator and positive pressure hood, centrifuge, and two stereomicroscopes. Two PC workstations with software for 3D rendering, quantitation and deconvolution of images (e.g. Velocity from Improvision, PowerMicrotome from Vaytech) are also provided. Maintenance contracts for major equipment and software support ensures consistent availability for users. Training/Expertise: The resource provides training to support use of current techniques and equipment and takes part in academic courses at Huntsman Cancer Institute (Cell and Molecular Biology II) and the School of Medicine (Light Microscopy and Digital Imaging). The director has experience imaging live and fixed cells and continues to receive training relevant to imaging techniques (e.g., a course in 3D imaging of live cells,Vancouver, BC, 2002). Continued education is required to maintain the level of expertise necessary to fulfill the resource mission. Development/Consultation: The director is a Ph.D.-level biologist with extensive experience in fluorescent cell imaging and quantitative analysis of image data. On-site development of image acquisition and quantitation protocols continues to expand this range of expertise, and is designed to promote collaborative projects among CCSG members.

Agency
National Institute of Health (NIH)
Institute
National Cancer Institute (NCI)
Type
Center Core Grants (P30)
Project #
2P30CA042014-17
Application #
6990203
Study Section
Subcommittee G - Education (NCI)
Project Start
2004-07-09
Project End
2006-04-30
Budget Start
2004-07-09
Budget End
2005-04-30
Support Year
17
Fiscal Year
2004
Total Cost
$10,475
Indirect Cost
Name
University of Utah
Department
Type
DUNS #
009095365
City
Salt Lake City
State
UT
Country
United States
Zip Code
84112
Pishas, Kathleen I; Drenberg, Christina D; Taslim, Cenny et al. (2018) Therapeutic Targeting of KDM1A/LSD1 in Ewing Sarcoma with SP-2509 Engages the Endoplasmic Reticulum Stress Response. Mol Cancer Ther 17:1902-1916
Blackburn, Brenna E; Ganz, Patricia A; Rowe, Kerry et al. (2018) Reproductive and gynecological complication risks among thyroid cancer survivors. J Cancer Surviv 12:702-711
Wu, Yelena P; Aspinwall, Lisa G; Nagelhout, Elizabeth et al. (2018) Development of an Educational Program Integrating Concepts of Genetic Risk and Preventive Strategies for Children with a Family History of Melanoma. J Cancer Educ 33:774-781
Kim, Hyung-Seok; McKnite, Autumn; Xie, Yuanyuan et al. (2018) Fibronectin type III and intracellular domains of Toll-like receptor 4 interactor with leucine-rich repeats (Tril) are required for developmental signaling. Mol Biol Cell 29:523-531
Spiker, William Ryan; Brodke, Darrel S; Goz, Vadim et al. (2018) Evidence of an Inherited Predisposition for Spinal Cord Tumors. Global Spine J 8:340-344
Ye, Zhizhou; Ayer, Donald E (2018) Ras Suppresses TXNIP Expression by Restricting Ribosome Translocation. Mol Cell Biol :
Fuller, Andrew K; Bice, Benjamin D; Venancio, Ashlee R et al. (2018) A Method to Define the Effects of Environmental Enrichment on Colon Microbiome Biodiversity in a Mouse Colon Tumor Model. J Vis Exp :
Wang, Sophia S; Carrington, Mary; Berndt, Sonja I et al. (2018) HLA Class I and II Diversity Contributes to the Etiologic Heterogeneity of Non-Hodgkin Lymphoma Subtypes. Cancer Res 78:4086-4096
Faham, Najme; Zhao, Ling; Welm, Alana L (2018) mTORC1 is a key mediator of RON-dependent breast cancer metastasis with therapeutic potential. NPJ Breast Cancer 4:36
Rengifo-Cam, William; Shepherd, Hailey M; Jasperson, Kory W et al. (2018) Colon Pathology Characteristics in Li-Fraumeni Syndrome. Clin Gastroenterol Hepatol 16:140-141

Showing the most recent 10 out of 1193 publications